A new health policy paper published in The Lancet medical journal concludes that U.S. and U.K. healthcare policy managers should learn from each other. The article, “Health Care Reforms in the USA and England: Areas for Useful Learning,” noted that both countries are under pressure to get more value out of health care spending and to reduce growth in costs. It also found that both are experimenting with new ways to achieve those goals.
AC Alert for October 18, 2012 When The Cure Is Worse Than The Ailment
When issue management can get very personal. You've heard the headline expression before. The cure/ailment equation can get very personal in our lives. When our friend Ted began experiencing that nagging pain in his leg again -- especially when standing for a while -- he figured it was probably his sciatica nerve acting up again. After all, he’s 61, and not growing any younger! Moreover, he’s had the pain on and off for several years.
MEMPHIS, Tenn., October 4, 2012 /3BL Media/ - With a current world population of more than seven billion, and expectations that number will exceed eight billion by 2030, the global healthcare industry is growing exponentially. But to achieve its potential, providers across the industry—from R&D and manufacturing to the caregivers themselves—must go “borderless.” This interconnected view of the industry’s future was the focus of the FedEx Corp. (NYSE: FDX) healthcare industry summit, held in New York City this week.
Novo Nordisk launches the Copenhagen Catalogue of Good Practices in Diabetes to facilitate knowledge sharing within the diabetes community.
(3BL Media) September 3, 2012 - Today the Copenhagen Catalogue, a collection of concrete examples of good practices in diabetes care, is being launched. The catalogue originates from the European Diabetes Leadership Forum which took place in Copenhagen on 25-26 April 2012 emphasising that sharing information about the many existing successful practices is crucial in times of financial crisis.
Some weeks ago our team approached me asking if I wanted to participate in the judging panel for the Harvard Innovation Lab (iLab). I immediately said yes because it was an opportunity for me to champion the idea of innovation in healthcare and see what others are doing.